Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05323656
Title A Study of Setanaxib Co-Administered With Pembrolizumab in Patients With Recurrent or Metastatic SCCHN
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Genkyotex Suisse SA

head and neck squamous cell carcinoma



Pembrolizumab + Setanaxib

Age Groups: adult | senior
Covered Countries FRA | ESP

No variant requirements are available.